Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

209 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical characteristics and molecular aspects of low-grade serous ovarian and peritoneal cancer: a multicenter, observational, retrospective analysis of MITO Group (MITO 22).
Musacchio L, Califano D, Bartoletti M, Arenare L, Lorusso D, Losito NS, Cormio G, Greggi S, Raspagliesi F, Valabrega G, Salutari V, Pisano C, Spina A, Russo D, Del Sesto M, Canzonieri V, Ferraù F, Zannoni GF, Loizzi V, Ghizzoni V, Casanova C, Tuninetti V, Ducceschi M, Del Vecchio V, Scalone S, Priolo D, Perrone F, Scambia G, Pignata S. Musacchio L, et al. Among authors: ferrau f. Br J Cancer. 2022 Nov;127(8):1479-1486. doi: 10.1038/s41416-022-01897-1. Epub 2022 Jul 22. Br J Cancer. 2022. PMID: 35869143 Free PMC article.
Supportive care in patients with advanced non-small-cell lung cancer.
Di Maio M, Perrone F, Gallo C, Iaffaioli RV, Manzione L, Piantedosi FV, Cigolari S, Illiano A, Barbera S, Robbiati SF, Piazza E, Ianniello GP, Frontini L, Veltri E, Castiglione F, Rosetti F, De Maio E, Maione P, Gridelli C, Rossi A, Barletta E, Barzelloni ML, Signoriello G, Bilancia D, Dinota A, Rosati G, Germano D, Lamberti A, Pontillo V, Brancacio L, Crispino C, Esposito M, Battiloro C, Tufano G, Cioffi A, Guardasole V, Angelini V, Guidetti G, Barbera S, Renda F, Romano F, Volpintesta A, Robbiati SF, Sannicolò M, Filipazzi V, Esani G, Gambaro A, Ferrario S, Tinessa V, Caprio MG, Zonato S, Cabiddu M, Raina A, Veltri E, D'Aprile M, Pistillucci G, Porcile G, Ostellino O, Vinante O, Azzarello G, Gebbia V, Borsellino N, Testa A, Gasparini G, Morabito A, Gattuso D, Romito S, Carrozza F, Fava S, Calcagno A, Grimi E, Bertetto O, Ciuffreda L, Parello G, Maiorino L, Santoro A, Santoro M, Failla G, Aiello RA, Bearz A, Sorio R, Scalone S, Clerici M, Bollina R, Belloni P, Sacco C, Sibau A, Adamo V, Altavilla G, Scimone A, Spatafora M, Bellia V, Hopps MR, Monfardini S, Favaretto A, Stefani M, Corradini GM, Pavia G, Scagliotti G, Novello S, Selvaggi G, Tonato M, Darwish S, Michetti G, Belomett… See abstract for full author list ➔ Di Maio M, et al. Among authors: ferrau f. Br J Cancer. 2003 Sep 15;89(6):1013-21. doi: 10.1038/sj.bjc.6601236. Br J Cancer. 2003. PMID: 12966418 Free PMC article.
[Antiblastic therapy and anticoagulation: a new frontier?].
Vitale F, Colina P, D'Angelo A, Priolo D, Ferraù F. Vitale F, et al. Among authors: ferrau f. Suppl Tumori. 2004 Mar-Apr;3(2):S33-5. Suppl Tumori. 2004. PMID: 15067963 Review. Italian. No abstract available.
Safety and activity of the combination of pegylated liposomal doxorubicin and weekly docetaxel in advanced breast cancer.
Morabito A, Gattuso D, Stani SC, Fanelli M, Ferraù F, De Sio L, Castellana MA, Lorusso V, Priolo D, Vitale S, Sarmiento R, Lo Vullo S, Mariani L, Gasparini G. Morabito A, et al. Among authors: ferrau f. Breast Cancer Res Treat. 2004 Aug;86(3):249-57. doi: 10.1023/B:BREA.0000036898.45123.e9. Breast Cancer Res Treat. 2004. PMID: 15567941 Clinical Trial.
Bevacizumab in the treatment of NSCLC: patient selection and perspectives.
Russo AE, Priolo D, Antonelli G, Libra M, McCubrey JA, Ferraù F. Russo AE, et al. Among authors: ferrau f. Lung Cancer (Auckl). 2017 Dec 14;8:259-269. doi: 10.2147/LCTT.S110306. eCollection 2017. Lung Cancer (Auckl). 2017. PMID: 29276417 Free PMC article. Review.
Activity and toxicity of gemcitabine and gemcitabine + vinorelbine in advanced non-small-cell lung cancer elderly patients: Phase II data from the Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trial.
Gridelli C, Cigolari S, Gallo C, Manzione L, Ianniello GP, Frontini L, Ferraù F, Robbiati SF, Adamo V, Gasparini G, Novello S, Perrone F; MILES Investigators. Gridelli C, et al. Among authors: ferrau f. Lung Cancer. 2001 Feb-Mar;31(2-3):277-84. doi: 10.1016/s0169-5002(00)00194-x. Lung Cancer. 2001. PMID: 11165408 Clinical Trial.
Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer.
Di Maio M, Gridelli C, Gallo C, Manzione L, Brancaccio L, Barbera S, Robbiati SF, Ianniello GP, Ferraù F, Piazza E, Frontini L, Rosetti F, Carrozza F, Bearz A, Spatafora M, Adamo V, Isa L, Iaffaioli RV, Di Salvo E, Perrone F. Di Maio M, et al. Among authors: ferrau f. Br J Cancer. 2004 Jun 14;90(12):2288-96. doi: 10.1038/sj.bjc.6601810. Br J Cancer. 2004. PMID: 15162156 Free PMC article. Clinical Trial.
A multicenter, randomized, Phase II study of cisplatin, etoposide, and gemcitabine or cisplatin plus gemcitabine as first-line treatment in patients with poor-prognosis small cell lung carcinoma.
De Marinis F, Nelli F, Lombardo M, Ferraú F, Barbera S, Bertetto O, Barni S, Michetti G, Labianca R, Gridelli C. De Marinis F, et al. Among authors: ferrau f. Cancer. 2005 Feb 15;103(4):772-9. doi: 10.1002/cncr.20859. Cancer. 2005. PMID: 15641037 Free article. Clinical Trial.
209 results